About Celentyx ltd
Celentyx Ltd: A Leading Immunology CRO for Immuno-Oncology, Autoimmunity, Inflammation, Fibrosis and Neuroinflammation Assays
Celentyx Ltd is a leading Contract Research Organization (CRO) that specializes in immunology research. The company offers a wide range of services to pharmaceutical and biotech companies, academic institutions and government agencies. Celentyx has extensive experience in immuno-oncology, autoimmunity, inflammation, fibrosis and neuroinflammation assays using healthy donor or patient tissues and cells.
The company was founded by Dr. Mike Clark in 2009 with the aim of providing high-quality immunological research services to clients worldwide. Since then, Celentyx has grown into a well-respected CRO with an excellent reputation for delivering reliable results on time.
Immunology is a complex field that requires specialized expertise to navigate successfully. Celentyx's team of experienced scientists has the knowledge and skills necessary to design and execute experiments that meet the highest scientific standards. The company's state-of-the-art facilities are equipped with cutting-edge technology that allows them to perform assays at the highest level of accuracy.
One area where Celentyx excels is immuno-oncology research. This field focuses on developing therapies that harness the power of the immune system to fight cancer. Celentyx offers a range of immuno-oncology assays including T cell activation assays, cytokine profiling assays and immune cell phenotyping assays.
Autoimmunity is another area where Celentyx has significant expertise. Autoimmune diseases occur when the body's immune system attacks its own tissues instead of foreign invaders like viruses or bacteria. These diseases can be challenging to diagnose and treat because they often have overlapping symptoms with other conditions.
Celentyx offers a range of autoimmunity assays including autoimmune disease profiling panels which measure levels of autoantibodies associated with specific autoimmune diseases. The company also offers T cell activation assays and cytokine profiling assays which can help identify the underlying mechanisms driving autoimmune diseases.
Inflammation is a common feature of many diseases, including autoimmune diseases, cancer and cardiovascular disease. Celentyx has extensive experience in measuring inflammatory markers using a range of techniques including ELISA, Luminex and flow cytometry.
Fibrosis is another area where Celentyx has significant expertise. Fibrosis occurs when excess connective tissue forms in an organ or tissue leading to scarring and impaired function. This process can occur in many different organs including the liver, lungs and kidneys.
Celentyx offers a range of fibrosis assays including collagen quantification assays, fibroblast proliferation assays and extracellular matrix remodeling assays. These tests can help identify potential drug targets for treating fibrotic diseases.
Neuroinflammation is an emerging field that focuses on the role of inflammation in neurological disorders such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. Celentyx has developed a range of neuroinflammation assays that measure levels of inflammatory markers in cerebrospinal fluid (CSF) or brain tissue samples.
Overall, Celentyx Ltd is a leading immunology CRO with extensive experience in immuno-oncology, autoimmunity, inflammation, fibrosis and neuroinflammation research. The company's team of experienced scientists uses state-of-the-art technology to deliver reliable results on time to clients worldwide. If you are looking for high-quality immunological research services from a trusted partner then look no further than Celentyx Ltd!